Press Releases

Roswell Park Cancer Institute faculty member and researcher Rodney Haring, PhD, MSW, will present his research, “Adapting assessment tools to measure obesity and cancer prevention: diet, physical activity, workplace productivity, and cancer knowledge” during a webinar hosted by the AcademyHealth/Aetna Foundation Scholars in Residence Fellowship Program.

Significant differences in attitudes toward smoking cessation are reported between two generations of smokers in Northern Appalachia in new research from Roswell Park Cancer Institute.

An innovative vaccine therapy developed at Roswell Park Cancer Institute is being tested in a multisite clinical trial involving 50 patients with newly diagnosed glioblastoma brain tumors. The phase II study, now accruing patients at both Roswell Park and the Cleveland Clinic, will assess the effectiveness of the SurVaxM vaccine in combination with standard chemotherapy as treatment for this often-fatal cancer.

Identifying patients at increased risk for ovarian cancer is key to prevention, early detection and ultimately improved survival. In a new article for the American Medical Association Journal of Ethics, two Roswell Park Cancer Institute physicians review the state of the science regarding the surgical removal of the fallopian tubes as an option to reduce the risk of the disease.

The U.S. Food and Drug Administration (FDA) is hosting an Ovarian Cancer Endpoints Workshop with presentations by the Society of Gynecologic Oncology, the American Association for Cancer Research and the American Society of Clinical Oncology, along with invited guest speakers, including Deputy Director of Roswell Park, Kunle Odunsi, MD, PhD, FRCOG, FACOG.

A history of oral contraceptive use and having at least one child increased longevity by nearly three years in patients diagnosed with ovarian cancer, according to a Roswell Park Cancer Institute study recently published online ahead of print in the International Journal of Gynecological Cancer.

A group of retired firefighters dedicated to raising funds for cancer research visited Roswell Park Cancer Institute today to make a significant donation that will go toward urologic cancer research, which includes prostate, bladder and kidney cancers among others.